GC Pharma, SK Plasma going global to offset blood shortage
IndustryFeb 11, 2020
GC Pharma and SK Plasma, the two South Korean companies that produce plasma-derived medical products, or PDMPs, are actively seeking overseas expansion to offset the limited blood supply in Korea. For companies that use human blood, or more specifically plasma, procuring sufficient amounts is the toughest obstacle to business. Blood can quite literally be turned into medicine once it is separated into its component parts. The red fluid running through our blood vessels is actually 55 percent